Delivery Order SPE2DB22D3011-SPE2DB24FQ2UX

Award Date 7/24/24
Potential Completion Date 7/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,886.90, is for the supply of 4567495266 CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of March 10, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, with a firm fixed price ceiling value of $6,523.61 and a period of performance through May 15, 2025. The contract is not set aside and was awarded on May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product. The contract has a ceiling value of $1,001.00 and is a firm fixed-price delivery order with a period of performance ending on June 17, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $6,223.72 and a performance period ending on May 22, 2025. The contract is a Firm Fixed Price type and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CLOBAZAM 10 MG TABLET 100S, with a ceiling value of $1,587.41. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565532789 - CLOBAZAM 10 MG TABLET 100S. The award has a firm fixed price of $6,296.78 and an ultimate completion date of August 22, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the DLA to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $2,016.73 for the supply of CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of July 2, 2025 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of the pharmaceutical product CLOBAZAM 10 MG TABLET 100S. The award has a ceiling value of $1,760.00 and a performance period ending on April 19, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,655.83, is for the delivery of 4,568,221,388 units of the pharmaceutical product CLOBAZAM 10 MG TABLET 100S. The contract is a firm fixed-price delivery order, with a completion date of May 13, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $5,266.23, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of CLOBAZAM 10 MG TABLET 100S. The contract has an ultimate completion date of June 6, 2025 and is structured as a firm fixed-price agreement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies,...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2UX
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565242653 CLOBAZAM 10 MG TABLET 100S. The delivery order has a ceiling value of $1,555.93 and a period of performance through July 25, 2024. This contract was not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous indefinite delivery contracts (IDCs) by the DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs, vaccines, and medical supplies, in support of military treatment facilities, veterans' healthcare, and other government healthcare programs.

Generated 10/23/24, 9:04 AM